Verastem (VSTM) Research Hub

Verastem (VSTM) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 10 USD (-0.40%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.36, market cap 0.41B. This hub links to the full technical, earnings and options research available for VSTM.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close10 USD (-0.40%)
52-week range3.44 USD – 10.22 USD
Trend regimeRange
14-day RSI68.7 (Bullish)
Trailing P/E-2.36
Market cap0.41B
Dividend yield0.00%
Next earnings2026-08-06

Available research for VSTM

Earnings

VSTM earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -2.36. Updated 2026-07-23.

Options: Covered Call

Covered Call on VSTM: how it works, illustrative setup around the real 10 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on VSTM: how it works, illustrative setup around the real 10 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on VSTM: how it works, illustrative setup around the real 10 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

VSTM technical analysis: range, last 10 USD, RSI 68.7, 52w range 3.44 USD–10.22 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is VSTM in?

Verastem (VSTM) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is VSTM in an uptrend or downtrend?

As of 2026-10-26, VSTM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is VSTM's trailing P/E ratio?

VSTM's trailing P/E is -2.36, with a market cap of 0.41B. See the earnings research page for full valuation detail.

When does VSTM next report earnings?

VSTM is next scheduled to report earnings on 2026-08-06.